Ascendis Pharma A/S annual gross profit
2019
2020
2021
2022
2023
2024
2025
Ascendis Pharma A/S Gross Profit Growth & History (ASND)
Ascendis Pharma A/S's gross profit was €625.2M for fiscal 2025.
View full Ascendis Pharma A/S company overviewAscendis Pharma A/S annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €625.2M | €305.8M | +95.76% |
| 2024 | 2024-12-31 | €319.4M | €97.1M | +43.66% |
| 2023 | 2023-12-31 | €222.3M | €183.3M | +469.52% |
| 2022 | 2022-12-31 | €39.0M | €34.8M | +817.44% |
| 2021 | 2021-12-31 | €4.3M | −€2.7M | −38.80% |
| 2020 | 2020-12-31 | €7.0M | −€6.4M | −48.01% |
| 2019 | 2019-12-31 | €13.4M | — | — |
Ascendis Pharma A/S quarterly gross profit
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €311.6M | €185.0M | +146.15% |
| Q1 2026 | 2026-03-31 | €229.1M | €145.6M | +174.56% |
| Q4 2025 | 2025-12-31 | €223.9M | €64.0M | +40.03% |
| Q3 2025 | 2025-09-30 | €191.3M | €144.6M | +310.19% |
| Q2 2025 | 2025-06-30 | €126.6M | €102.1M | +416.03% |
| Q1 2025 | 2025-03-31 | €83.4M | −€4.9M | −5.53% |
| Q4 2024 | 2024-12-31 | €159.9M | €41.6M | +35.22% |
| Q3 2024 | 2024-09-30 | €46.6M | €6.0M | +14.73% |
| Q2 2024 | 2024-06-30 | €24.5M | −€9.9M | −28.82% |
| Q1 2024 | 2024-03-31 | €88.3M | €59.4M | +204.91% |
| Q4 2023 | 2023-12-31 | €118.2M | €100.5M | +564.90% |
| Q3 2023 | 2023-09-30 | €40.6M | €27.0M | +198.93% |
| Q2 2023 | 2023-06-30 | €34.5M | €29.4M | +579.23% |
| Q1 2023 | 2023-03-31 | €29.0M | €26.4M | +1021.92% |
| Q4 2022 | 2022-12-31 | €17.8M | €16.4M | +1194.32% |
| Q3 2022 | 2022-09-30 | €13.6M | €12.5M | +1121.65% |
| Q2 2022 | 2022-06-30 | €5.1M | €4.1M | +396.48% |
| Q1 2022 | 2022-03-31 | €2.6M | €1.8M | +246.11% |
| Q4 2021 | 2021-12-31 | €1.4M | — | — |
| Q3 2021 | 2021-09-30 | €1.1M | — | — |
| Q2 2021 | 2021-06-30 | €1.0M | — | — |
| Q1 2021 | 2021-03-31 | €746,000 | — | — |
Ascendis Pharma A/S gross profit trends
Over the last five fiscal years, Ascendis Pharma A/S's gross profit increased from €7.0M to €625.2M, a change of €618.3M. The latest reported quarter, Q2 2026, shows €311.6M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ascendis Pharma A/S source filings ↗